Atlas Trials

Uvax Bio LLC

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Uvax Bio LLC

RecordFirmDate
Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years. (NCT06541093)Uvax Bio LLC2024-01-30

Track Uvax Bio LLC automatically

Every clearance here is in the API, with alerts when new ones post.